Windtree Therapeutics Inc...

NASDAQ: WINT · Real-Time Price · USD
0.51
-0.01 (-1.28%)
At close: Aug 15, 2025, 3:02 PM

Windtree Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 82K 1.06M 869K
Gross Profit
n/a -82K -1.06M -869K
Operating Income
-25.02M -20.6M -41.33M -77.28M
Interest Income
70K 325K 109K 91K
Pretax Income
-1.79M -20.29M -40.58M -77.62M
Net Income
-5.49M -20.29M -39.21M -67.64M
Selling & General & Admin
8.74M 9.2M 10.79M 14.47M
Research & Development
16.28M 8.26M 11.1M 17.79M
Other Expenses
1.12M 3.56M 702K -320K
Operating Expenses
26.14M 20.6M 21.89M 32.26M
Interest Expense
235K 50K 53K 114K
Selling & Marketing Expenses
n/a 9.19M n/a n/a
Cost & Expenses
n/a 17.54M 21.89M 32.26M
Income Tax Expense
3.69M n/a -1.37M -9.99M
Shares Outstanding (Basic)
52.58K 4.31K 700.00 550.22
Shares Outstanding (Diluted)
52.58K 4.31K 700.00 550.22
EPS (Basic)
-104.35 -4.71K -56.01K -122.92K
EPS (Diluted)
-104.35 -4.71K -56.01K -122.92K
EBITDA
n/a -20.16M -39.46M -76.64M
EBIT
-1.56M -20.24M -40.52M -77.51M
Depreciation & Amortization
n/a 82K 1.06M 869K